Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort
The Prostate ( IF 2.6 ) Pub Date : 2021-07-12 , DOI: 10.1002/pros.24195 Jun Wei 1, 2 , Wancai Yang 3 , Zhuqing Shi 1, 2 , Lucy Lu 3 , Qiang Wang 3 , W Kyle Resurreccion 1, 2 , Valentina Engelmann 3 , S Lilly Zheng 1, 2 , Peter J Hulick 4 , Kathleen A Cooney 5 , William B Isaacs 6 , Brian T Helfand 1, 2 , Jim Lu 3 , Jianfeng Xu 1, 2
The Prostate ( IF 2.6 ) Pub Date : 2021-07-12 , DOI: 10.1002/pros.24195 Jun Wei 1, 2 , Wancai Yang 3 , Zhuqing Shi 1, 2 , Lucy Lu 3 , Qiang Wang 3 , W Kyle Resurreccion 1, 2 , Valentina Engelmann 3 , S Lilly Zheng 1, 2 , Peter J Hulick 4 , Kathleen A Cooney 5 , William B Isaacs 6 , Brian T Helfand 1, 2 , Jim Lu 3 , Jianfeng Xu 1, 2
Affiliation
Germline testing for prostate cancer (PCa) is now recommended by the National Comprehensive Cancer Network. While multi-gene testing has been proposed, evidence for their association with PCa risk is not well established.
中文翻译：
从大型人群队列中观察到指南推荐基因预测前列腺癌风险的证据
国家综合癌症网络现在建议对前列腺癌 (PCa) 进行生殖系检测。虽然已经提出了多基因检测，但它们与 PCa 风险相关的证据尚未得到充分确立。
更新日期：2021-08-13
中文翻译：
从大型人群队列中观察到指南推荐基因预测前列腺癌风险的证据
国家综合癌症网络现在建议对前列腺癌 (PCa) 进行生殖系检测。虽然已经提出了多基因检测，但它们与 PCa 风险相关的证据尚未得到充分确立。
京公网安备 11010802027423号